Penumbra SG&A Expenses 2014-2025 | PEN

Penumbra annual/quarterly sg&a expenses history and growth rate from 2014 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Penumbra sg&a expenses for the quarter ending March 31, 2025 were $0.153B, a 6.26% increase year-over-year.
  • Penumbra sg&a expenses for the twelve months ending March 31, 2025 were $0.583B, a 10.47% increase year-over-year.
  • Penumbra annual sg&a expenses for 2024 were $0.574B, a 13.33% increase from 2023.
  • Penumbra annual sg&a expenses for 2023 were $0.506B, a 12.62% increase from 2022.
  • Penumbra annual sg&a expenses for 2022 were $0.45B, a 18.87% increase from 2021.
Penumbra Annual SG&A Expenses
(Millions of US $)
2024 $574
2023 $506
2022 $450
2021 $378
2020 $287
2019 $273
2018 $226
2017 $184
2016 $148
2015 $102
2014 $64
2013 $45
Penumbra Quarterly SG&A Expenses
(Millions of US $)
2025-03-31 $153
2024-12-31 $148
2024-09-30 $140
2024-06-30 $142
2024-03-31 $144
2023-12-31 $130
2023-09-30 $126
2023-06-30 $127
2023-03-31 $123
2022-12-31 $116
2022-09-30 $109
2022-06-30 $115
2022-03-31 $111
2021-12-31 $114
2021-09-30 $94
2021-06-30 $91
2021-03-31 $80
2020-12-31 $77
2020-09-30 $76
2020-06-30 $60
2020-03-31 $74
2019-12-31 $75
2019-09-30 $69
2019-06-30 $68
2019-03-31 $61
2018-12-31 $61
2018-09-30 $56
2018-06-30 $55
2018-03-31 $54
2017-12-31 $51
2017-09-30 $46
2017-06-30 $44
2017-03-31 $43
2016-12-31 $42
2016-09-30 $38
2016-06-30 $36
2016-03-31 $33
2015-12-31 $29
2015-09-30 $27
2015-06-30 $26
2015-03-31 $20
2014-12-31
2014-09-30 $17
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.920B $1.195B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $198.309B 86.86
Thermo Fisher Scientific (TMO) United States $149.665B 18.10
Edwards Lifesciences (EW) United States $45.813B 30.04
Alcon (ALC) Switzerland $42.010B 28.39
IDEXX Laboratories (IDXX) United States $41.401B 47.58
DexCom (DXCM) United States $33.529B 51.82
IQVIA Holdings (IQV) United States $24.064B 13.48
STERIS (STE) Ireland $23.814B 26.23
Mettler-Toledo (MTD) United States $23.716B 28.20
Waters (WAT) United States $20.452B 28.86
SONOVA HOLDING (SONVY) Switzerland $18.615B 0.00
Hologic (HOLX) United States $13.819B 15.02
Sysmex ADR (SSMXY) Japan $10.581B 30.02
Masimo (MASI) United States $8.948B 33.01
Globus Medical (GMED) United States $7.982B 19.02
Glaukos (GKOS) United States $5.416B 0.00
Teleflex (TFX) United States $5.288B 8.73
TransMedics (TMDX) United States $4.192B 91.13
Integer Holdings (ITGR) United States $4.106B 21.52
PROCEPT BioRobotics (PRCT) United States $3.206B 0.00
LivaNova (LIVN) United Kingdom $2.367B 14.09
Veracyte (VCYT) United States $2.094B 29.39
Nihon Kohden (NHNKY) Japan $2.022B 23.19
Elekta AB (EKTAY) Sweden $1.985B 17.84
Alphatec Holdings (ATEC) United States $1.798B 0.00
Tandem Diabetes Care (TNDM) United States $1.347B 0.00
Artivion (AORT) United States $1.226B 114.84
Pulse Biosciences (PLSE) United States $1.136B 0.00
OPKO Health (OPK) United States $1.094B 0.00
Integra LifeSciences Holdings (IART) United States $0.957B 5.09
Beta Bionics (BBNX) United States $0.810B 0.00
SiBone (SIBN) United States $0.804B 0.00
IRadimed (IRMD) United States $0.735B 37.28
RxSight (RXST) United States $0.631B 0.00
Delcath Systems (DCTH) United States $0.568B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.559B 8.69
Mesa Laboratories (MLAB) United States $0.534B 12.53
AxoGen (AXGN) United States $0.500B 0.00
OrthoPediatrics (KIDS) United States $0.485B 0.00
NeuroPace (NPCE) United States $0.428B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.425B 0.00
Semler Scientific (SMLR) United States $0.397B 10.56
AngioDynamics (ANGO) United States $0.394B 0.00
Treace Medical Concepts (TMCI) United States $0.361B 0.00
ClearPoint Neuro (CLPT) United States $0.330B 0.00
Pacific Biosciences Of California (PACB) United States $0.296B 0.00
Neuronetics (STIM) United States $0.251B 0.00
Tactile Systems Technology (TCMD) United States $0.230B 13.93
908 Devices (MASS) United States $0.213B 0.00
Alpha Tau Medical (DRTS) Israel $0.206B 0.00
Sight Sciences (SGHT) United States $0.201B 0.00
Biosig Technologies (BSGM) United States $0.192B 0.00
Inogen (INGN) United States $0.171B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
CVRx (CVRX) United States $0.169B 0.00
Anteris Technologies Global (AVR) Australia $0.167B 0.00
Accuray (ARAY) United States $0.160B 0.00
LENSAR (LNSR) United States $0.159B 0.00
Rapid Micro Biosystems (RPID) United States $0.151B 0.00
Lucid Diagnostics (LUCD) United States $0.135B 0.00
Atossa Genetics (ATOS) United States $0.112B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
Monogram Orthopaedics (MGRM) United States $0.086B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.078B 47.20
EDAP TMS S.A (EDAP) France $0.068B 0.00
Hyperfine (HYPR) United States $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Positron (POSC) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.045B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
NexGel (NXGL) United States $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.46
Longview Acquisition II (LGV) United States $0.000B 0.00